• EI
  • Scopus
  • 食品科学与工程领域高质量科技期刊分级目录第一方阵T1
  • DOAJ
  • EBSCO
  • 北大核心期刊
  • 中国核心学术期刊RCCSE
  • JST China
  • FSTA
  • 中国精品科技期刊
  • 中国农业核心期刊
  • CA
  • WJCI
  • 中国科技核心期刊CSTPCD
  • 中国生物医学SinoMed
中国精品科技期刊2020
苏硕楠,侯林中. 三种益生菌与低聚果糖复合粉对小鼠免疫功能的影响[J]. 食品工业科技,2022,43(11):363−368. doi: 10.13386/j.issn1002-0306.2021090063.
引用本文: 苏硕楠,侯林中. 三种益生菌与低聚果糖复合粉对小鼠免疫功能的影响[J]. 食品工业科技,2022,43(11):363−368. doi: 10.13386/j.issn1002-0306.2021090063.
SU Shuonan, HOU Linzhong. Immunomodulatory Effect of Triple Probiotics and Fructo-Oligosaccharide Compound Powder in Mice[J]. Science and Technology of Food Industry, 2022, 43(11): 363−368. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2021090063.
Citation: SU Shuonan, HOU Linzhong. Immunomodulatory Effect of Triple Probiotics and Fructo-Oligosaccharide Compound Powder in Mice[J]. Science and Technology of Food Industry, 2022, 43(11): 363−368. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2021090063.

三种益生菌与低聚果糖复合粉对小鼠免疫功能的影响

Immunomodulatory Effect of Triple Probiotics and Fructo-Oligosaccharide Compound Powder in Mice

  • 摘要: 目的:研究三种乳酸菌(乳双歧杆菌V9、干酪乳杆菌Zhang、植物乳杆菌P-8)与低果聚糖复配的益生复合粉(BLLF)对小鼠免疫功能的调控作用。方法:取C57BL/6J小鼠分别每日灌胃给予蒸馏水(空白对照,0.1 mL/10 g)和不同剂量的BLLF(三联菌0.01 mg/kg+低聚果糖0.1 g/kg、三联菌0.02 mg/kg+低聚果糖0.1 g/kg、三联菌0.06 mg/kg+低聚果糖0.1 g/kg)0.1 mL/10 g体重,每日灌胃1次,连续30 d,测定小鼠脏器与体重比;检测各组小鼠的细胞免疫功能、单核-巨噬细胞功能、体液免疫功能及NK细胞活性。结果:与对照组相比,BLLF对小鼠体重、胸腺/体重比值、脾脏/体重比值均无显著影响(P>0.05);与对照组相比,低、中、高剂量的BLLF对ConA诱导小鼠脾淋巴细胞增殖无显著影响(P>0.05);迟发型变态反应结果表明,中、高剂量BLLF组的小鼠耳廓肿胀度显著高于对照组(P < 0.05);中、高剂量BLLF组小鼠碳廓清功能显著高于对照组(P < 0.05);中、高剂量BLLF组小鼠的抗体生成细胞数及半数溶血值均显著高于对照组(P < 0.05);中、高剂量BLLF组小鼠NK细胞活性显著高于对照组(P < 0.05)。结论:BLLF可通过增强细胞免疫、单核-巨噬细胞功能、体液免疫及NK细胞活性来增强小鼠的免疫功能。

     

    Abstract: Objective: The present study aimed to evaluate immunomodulatory effects of triple probiotics (Bifidobacterium lactis V9/Lactobacillus plantarum P-8/Lactobacillus casei Zhang) and fructo-oligosaccharide (BLLF) in mice and its mechanism. Methods: C57BL/6J mice received intragastric administration of distilled water (control group 0.1 mL/10 g) and different doses of BLLF (triple probiotics 0.01 mg/kg+fructo-oligosaccharide 0.1 g/kg, triple probiotics 0.02 mg/kg+fructo-oligosaccharide 0.1 g/kg, and triple probiotics 0.06 mg/kg+fructo-oligosaccharide 0.1 g/kg) 0.1 mL/10 g once daily for 30 days. The immunity of mice was evaluated by organ ratios. The function of cellular immunity, monocyte macrophage, humoral immunity, and NK cell activities of the mice were further evaluated. Results: Compared with the control group, low, medium and high dose BLLF showed no significant effects on body weights and organ ratios of the mice(P>0.05). BLLF showed no significant effects on ConA-induced mouse splenic lymphocyte proliferations(P>0.05). Medium and high dose BLLF significantly increased the delayed hypersensitivity induced by dinitrofluorobenzene in mice (P < 0.05). The macrophage carbon clearance function of mice in high dose BLLF group was significantly increased compared with the control group (P < 0.05). Medium and high dose BLLF significantly increased the mouse peritoneal macrophage phagocytosis of chicken red blood cells(P < 0.05). Medium and high dose BLLF significantly increased hemolytic activity and number of antibody producing cells in mice (P < 0.05). Medium and high dose BLLF significantly increased NK cell activities in mice (P < 0.05). Conclusions: BLLF exhibited potent immunomodulatory effects by increasing cellular immunity, humoral immunity, function of monocyte macrophage, and NK cell activity.

     

/

返回文章
返回